Organon & Co. (OGN)

NYSE: OGN · Real-Time Price · USD

6.56

-0.15 (-2.24%)

At close: Mar 6, 2026, 4:00 PM EST

6.60

+0.04 (0.61%)

After-hours: Mar 6, 2026, 7:59 PM EST

Organon & Co. Employees

Organon & Co. had 10,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.

Employees

10,000

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$621,600

Profits / Employee

$18,700

Market Cap

1.71B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2025	10,000	0	-
Dec 31, 2024	10,000	0	-
Dec 31, 2023	10,000	0	-
Dec 31, 2022	10,000	700	7.53%
Dec 31, 2021	9,300	-	-

Related Stocks

Company Name	Employees
Pfizer	75,000
Sanofi	74,846
GSK plc	68,629
Bristol-Myers Squibb Company	32,500
Grifols	23,737
Biogen	7,500
Amarin Corporation	275
Scilex Holding Company	30

Employee Rankings

OGN News

4 days ago - KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS - GlobeNewsWire
8 days ago - New Analysis of Organon's VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis - Business Wire
12 days ago - Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device - Business Wire
13 days ago - Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty - Seeking Alpha
23 days ago - Organon Q4 Earnings Review: Poor Results Trigger Predictable Sell-Off - Seeking Alpha
23 days ago - Organon & Co. (OGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
23 days ago - Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - Business Wire
5 weeks ago - Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026 - Business Wire